The insider sales are routine and likely tied to option exercises and tax planning, not a negative signal. The larger story is the $477.6M ASR, which signals management's confidence in the stock's value. Monitor for any insider purchases or changes to the buyback program.
Price Chart
Executive Summary
A cluster of insider sales at United Therapeutics follows the company's $477.6M accelerated share repurchase agreement. The CEO, General Counsel, and a director sold a total of $348K in open-market sales, which is trivial relative to the company's market cap. The sales are likely liquidity-driven after option exercises and do not signal material negative information.
Key Financial Metrics
Key Facts
- Three insiders sold a total of $348K in open-market sales over a 5-day window (Sept 14-18, 2026).
- CEO Martine Rothblatt sold $122K, General Counsel Paul Mahon sold $161K, Director Nilda Mesa sold $66K.
- Both CEO and General Counsel also exercised stock options on Sept 17, with the sales likely covering taxes or diversifying.
- On Sept 8, 2026, the company entered a $477.6M accelerated share repurchase agreement with Citibank.
- Total insider sales of $348K represent less than 0.01% of the company's market cap (approximately $23B based on ~46M shares at ~$500).
Financial Impact
Insider sales of $348K are immaterial relative to the company's ~$23B market cap.
Risk Factors
- Insider sales could accelerate if the stock continues to rise, but current levels are not alarming.
- The ASR settlement in Q4 2026 could create modest price support or volatility depending on final share count.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-UTHR-1790024196942 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | Insider Cluster | $587.50 | awaiting T+5 | — | $592.84 (+0.91%) |
Oct 22, 2026 4d ago | 8-K | $584.79 | awaiting T+5 | — | $592.84 (+1.38%) |
Oct 22, 2026 5d ago | Insider Cluster | $587.50 | awaiting T+5 | — | $592.84 (−0.91%) |
Oct 21, 2026 5d ago | Insider Cluster | $584.79 | awaiting T+5 | — | $592.84 (+1.38%) |
Oct 20, 2026 6d ago | Insider Cluster | $563.49 | awaiting T+5 | — | $592.84 (+5.21%) |
Oct 19, 2026 8d ago | Insider Cluster | $553.88 | awaiting T+5 | — | $592.84 (+7.03%) |
Oct 16, 2026 10d ago | Insider Cluster | $543.15 $592.84 | ▲ +9.15% | ▲ +9.29% | $592.84 (+9.15%) |
Oct 14, 2026 12d ago | 8-K | $540.03 $563.49 | ▲ +4.34% | ▲ +3.89% | $592.84 (+9.78%) |
Oct 5, 2026 21d ago | Insider Cluster | $541.62 $543.40 | ▼ −0.33% | ▼ −0.47% | $592.84 (−9.46%) |
Oct 2, 2026 24d ago | Insider Cluster | $536.40 $550.10 | ▲ +2.55% | ▲ +2.13% | $592.84 (+10.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers